These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15578952)

  • 41. Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma.
    Nishimura A; Akeda K; Matsubara T; Kusuzaki K; Matsumine A; Masuda K; Gemba T; Uchida A; Sudo A
    Cancer Gene Ther; 2011 Apr; 18(4):250-9. PubMed ID: 21183950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.
    Tomita T; Takeuchi E; Tomita N; Morishita R; Kaneko M; Yamamoto K; Nakase T; Seki H; Kato K; Kaneda Y; Ochi T
    Arthritis Rheum; 1999 Dec; 42(12):2532-42. PubMed ID: 10615998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent progress in gene therapy for cardiovascular disease.
    Morishita R
    Circ J; 2002 Dec; 66(12):1077-86. PubMed ID: 12499610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of ultraviolet-induced apoptosis by NF-kappaB decoy oligonucleotides.
    Yokoyama S; Nakano H; Yamazaki T; Tamai K; Hanada K; Takahashi G
    Br J Dermatol; 2005 Dec; 153 Suppl 2():47-51. PubMed ID: 16280021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model.
    Yamasaki K; Asai T; Shimizu M; Aoki M; Hashiya N; Sakonjo H; Makino H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2003 Feb; 10(4):356-64. PubMed ID: 12595894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of novel decoy oligonucleotides: advantages of circular dumb-bell decoy.
    Tomita N; Tomita T; Yuyama K; Tougan T; Tajima T; Ogihara T; Morishita R
    Curr Opin Mol Ther; 2003 Apr; 5(2):107-12. PubMed ID: 12772498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A genomic-scale view of the cAMP response element-enhancer decoy: a tumor target-based genetic tool.
    Cho YS; Kim MK; Cheadle C; Neary C; Park YG; Becker KG; Cho-Chung YS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15626-31. PubMed ID: 12438686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increase in nuclease resistance and incorporation of NF-kappaB decoy oligodeoxynucleotides by modification of the 3'-terminus.
    Osako MK; Tomita N; Nakagami H; Kunugiza Y; Yoshino M; Yuyama K; Tomita T; Yoshikawa H; Ogihara T; Morishita R
    J Gene Med; 2007 Sep; 9(9):812-9. PubMed ID: 17640082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A nucleic acid-based medication for allergic skin diseases.
    Yokozeki H
    J Dermatol Sci; 2014 Aug; 75(2):75-81. PubMed ID: 24726501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A Decoy Oligodeoxynucleotides therapy for allergic skin diseases].
    Yokozeki H
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(2):107-11. PubMed ID: 22576567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts.
    Shimizu H; Nakagami H; Tsukamoto I; Morita S; Kunugiza Y; Tomita T; Yoshikawa H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2006 Jun; 13(12):933-41. PubMed ID: 16511526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts.
    Vos IH; Govers R; Gröne HJ; Kleij L; Schurink M; De Weger RA; Goldschmeding R; Rabelink TJ
    FASEB J; 2000 Apr; 14(5):815-22. PubMed ID: 10744638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model.
    Ogushi I; Iimuro Y; Seki E; Son G; Hirano T; Hada T; Tsutsui H; Nakanishi K; Morishita R; Kaneda Y; Fujimoto J
    Hepatology; 2003 Aug; 38(2):335-44. PubMed ID: 12883477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.
    Maeshima Y; Kashihara N; Yasuda T; Sugiyama H; Sekikawa T; Okamoto K; Kanao K; Watanabe Y; Kanwar YS; Makino H
    J Clin Invest; 1998 Jun; 101(11):2589-97. PubMed ID: 9616230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-stranded RNA transcribed from vector-based oligodeoxynucleotide acts as transcription factor decoy.
    Xiao X; Gang Y; Wang H; Wang J; Zhao L; Xu L; Liu Z
    Biochem Biophys Res Commun; 2015 Feb; 457(2):221-6. PubMed ID: 25550185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.
    Souissi I; Najjar I; Ah-Koon L; Schischmanoff PO; Lesage D; Le Coquil S; Roger C; Dusanter-Fourt I; Varin-Blank N; Cao A; Metelev V; Baran-Marszak F; Fagard R
    BMC Cell Biol; 2011 Apr; 12():14. PubMed ID: 21486470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-oxidant gene therapy by NF kappa B decoy oligodeoxynucleotide.
    Nakagami H; Tomita N; Kaneda Y; Ogihara T; Morishita R
    Curr Pharm Biotechnol; 2006 Apr; 7(2):95-100. PubMed ID: 16724943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells].
    Lu JP; Sun H; Cao CC; Ou ZL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):533-7. PubMed ID: 15363352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model.
    Yokozeki H; Wu MH; Sumi K; Awad S; Satoh T; Katayama I; Takeda K; Akira S; Kaneda Y; Nishioka K
    Gene Ther; 2004 Dec; 11(24):1753-62. PubMed ID: 15306842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oligonucleotides as transcription factor decoys.
    Cho-Chung YS; Park YG; Lee YN
    Curr Opin Mol Ther; 1999 Jun; 1(3):386-92. PubMed ID: 11713803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.